The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

CHEMBL82327     (2R)-2-[[4-[(3- fluorophenyl)methoxy]phenyl...

Synonyms: AC1NUPG0, SureCN194169, CHEBI:235095, DNC013330, M6252, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Fce-26743

 

High impact information on Fce-26743

 

Biological context of Fce-26743

 

Analytical, diagnostic and therapeutic context of Fce-26743

References

  1. Improvement of motor function in early Parkinson disease by safinamide. Stocchi, F., Arnold, G., Onofrj, M., Kwiecinski, H., Szczudlik, A., Thomas, A., Bonuccelli, U., Van Dijk, A., Cattaneo, C., Sala, P., Fariello, R.G. Neurology (2004) [Pubmed]
  2. Safinamide: from molecular targets to a new anti-Parkinson drug. Caccia, C., Maj, R., Calabresi, M., Maestroni, S., Faravelli, L., Curatolo, L., Salvati, P., Fariello, R.G. Neurology (2006) [Pubmed]
  3. Pressor response to intravenous tyramine in healthy subjects after safinamide, a novel neuroprotectant with selective, reversible monoamine oxidase B inhibition. Cattaneo, C., Caccia, C., Marzo, A., Maj, R., Fariello, R.G. Clinical neuropharmacology. (2003) [Pubmed]
  4. Safinamide. Fariello, R.G. Neurotherapeutics (2007) [Pubmed]
  5. Symptom relief in Parkinson disease by safinamide: Biochemical and clinical evidence of efficacy beyond MAO-B inhibition. Stocchi, F., Vacca, L., Grassini, P., De Pandis, M.F., Battaglia, G., Cattaneo, C., Fariello, R.G. Neurology (2006) [Pubmed]
  6. Bioassay of safinamide in biological fluids of humans and various animal species. Dal Bo, L., Mazzucchelli, P., Fibbioli, M., Marzo, A. Arzneimittel-Forschung (2006) [Pubmed]
  7. Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity. Marzo, A., Dal Bo, L., Monti, N.C., Crivelli, F., Ismaili, S., Caccia, C., Cattaneo, C., Fariello, R.G. Pharmacol. Res. (2004) [Pubmed]
 
WikiGenes - Universities